Effects of anti‐IL5 biological treatments on blood IgE levels in severe asthmatic patients: A real‐life multicentre study (BIONIGE)

Effects of anti‐IL5 biological treatments on blood IgE levels in severe asthmatic patients: A real‐life multicentre study (BIONIGE)

Abstract Background Mepolizumab and benralizumab are clinically effective biological treatments for severe eosinophilic asthmatic patients by hampering eosinophilic inflammation. The effects of these compound on the immunoglobulin (Ig)E T2 component are virtually unknown. Objectives To evaluate the...

Full description

Bibliographic Details
Main Authors: Marco Contoli, Pierachille Santus, Francesco Menzella, Cindy Rocchi, Dejan Radovanovic, Federico Baraldi, Chiara Martelli, Serena Casanova, Carlo Barbetta, Claudio Micheletto, Nicola Scichilone, Bianca Beghè, Elisiana Carpagnano, Alberto Papi
Format: Article
Language:English
Published: Wiley 2022-04-01
Series:Clinical and Translational Allergy
Subjects:
basophils
benralizumab
eosinophils
Ig‐E
mepolizumab
severe asthma
Online Access:https://doi.org/10.1002/clt2.12143

Internet

https://doi.org/10.1002/clt2.12143

Similar Items